Revenue
attach_money875M USD
YoY +94.1%
BCRXBioCryst Pharmaceuticals, Inc.$ --
BioCryst Pharmaceuticals, Inc.
BCRX
$ -
-
You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.
analyticsIncome Statement Summary
FY2025 Full YearUpdated: 12/31/2025
Operating Income
bar_chart341M USD
YoY +13508.9%
Net Income
verified264M USD
YoY +396.9%
EPS
pie_chart1.26USD
YoY +393.0%
Quarterly Performance
Quarterly revenue and net income trend
RevenueOperating IncomeNet Income
No quarterly data available
Full-Year Progress
Net Income Progress674.8%On Track
Revenue Progress874.8M
Revenue Forecast619.5M
Net Income Progress263.9M
Net Income Forecast39.1M
Income Statement Details
Item
Revenue
Cost of revenue
Gross profit
Research & development
Selling & marketing
Selling, general and administrative
Other operating expenses
Operating income
Interest expense
Income before tax
Income tax expense
Net income
Unlock Long-Term Income Statement Data
Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.